https://www.selleckchem.com/pr....oducts/gsk2256098.ht
5 vs. 19months, p=0.001). In the VETC-negative cohort, no significant differences in DFS and OS rates between the RHR and RFA groups were observed (p0.05). The results of our study suggested that RHR was relatively safe and superior to RFA in improving survival outcomes for recurrent early-stage HCC after initial hepatectomy. Furthermore, the VETC pattern may represent a reliable marker for selecting HCC patients who may benefit from RHR. The results of our study suggested that RHR was relatively safe and superior to RFA in impro